Healthequity Inc (NASDAQ: HQY) has a price-to-earnings ratio that is above its average at 65.13x. The stock has a 36-month beta value of 0.53. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for HQY is 85.26M, and at present, short sellers hold a 5.02% of that float. On October 04, 2024, the average trading volume of HQY was 650.55K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HQY) stock’s latest price update
Healthequity Inc (NASDAQ: HQY) has seen a decline in its stock price by -1.16 in relation to its previous close of 79.10. However, the company has experienced a -0.58% decline in its stock price over the last five trading sessions. zacks.com reported 2024-10-03 that HealthEquity (HQY) reported earnings 30 days ago. What’s next for the stock?
HQY’s Market Performance
Healthequity Inc (HQY) has seen a -0.58% fall in stock performance for the week, with a -5.42% decline in the past month and a -5.32% plunge in the past quarter. The volatility ratio for the week is 2.79%, and the volatility levels for the past 30 days are at 2.78% for HQY. The simple moving average for the past 20 days is -0.07% for HQY’s stock, with a 0.22% simple moving average for the past 200 days.
Analysts’ Opinion of HQY
Many brokerage firms have already submitted their reports for HQY stocks, with JMP Securities repeating the rating for HQY by listing it as a “Mkt Outperform.” The predicted price for HQY in the upcoming period, according to JMP Securities is $101 based on the research report published on April 04, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see HQY reach a price target of $108, previously predicting the price at $86. The rating they have provided for HQY stocks is “Overweight” according to the report published on April 02nd, 2024.
Barclays gave a rating of “Overweight” to HQY, setting the target price at $84 in the report published on January 03rd of the current year.
HQY Trading at 2.28% from the 50-Day Moving Average
After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.42% of loss for the given period.
Volatility was left at 2.78%, however, over the last 30 days, the volatility rate increased by 2.79%, as shares sank -1.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.03% upper at present.
During the last 5 trading sessions, HQY fell by -0.58%, which changed the moving average for the period of 200-days by +25.21% in comparison to the 20-day moving average, which settled at $78.17. In addition, Healthequity Inc saw 17.92% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HQY starting from Corvino Frank, who sale 1,247 shares at the price of $80.26 back on Oct 01 ’24. After this action, Corvino Frank now owns 4,823 shares of Healthequity Inc, valued at $100,090 using the latest closing price.
Kessler Jon, the PRESIDENT AND CEO of Healthequity Inc, sale 20,999 shares at $78.42 during a trade that took place back on Sep 16 ’24, which means that Kessler Jon is holding 204,502 shares at $1,646,796 based on the most recent closing price.
Stock Fundamentals for HQY
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.58 for the gross margin
The net margin for Healthequity Inc stands at 0.1. The total capital return value is set at 0.05. Equity return is now at value 5.15, with 3.21 for asset returns.
Based on Healthequity Inc (HQY), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 3.24.
Currently, EBITDA for the company is 281.21 million with net debt to EBITDA at 2.54. When we switch over and look at the enterprise to sales, we see a ratio of 6.97. The receivables turnover for the company is 10.13for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
To sum up, Healthequity Inc (HQY) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
